The problem is they don't have the money to do all these changes, maybe better for APPA to sell this drug to someone with better cashflow who can gets things completed. APPA might be good for bounce right now.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.